Skip to main content
$165.63 -$3.12 (-1.8%)

04:00 PM EDT on 10/26/21

10x Genomics (NASDAQ:TXG)

CAPS Rating: 4 out of 5

Current Price $165.63 Mkt Cap $18.7B
Open $169.71 P/E Ratio 0.00
Prev. Close $165.63 Div. (Yield) $0.00 (0.0%)
Daily Range $164.70 - $170.47 Volume 463,881
52-Wk Range $125.84 - $208.99 Avg. Daily Vol. 640,369

Caps

How do you think NASDAQ:TXG will perform against the market?

Add Stock to CAPS Watchlist

All Players

87 Outperform
1 Underperform
 

All-Star Players

29 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:TXG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

johnny05 (24.86)
Submitted February 18, 2021

Genomics is where you want to invest the next few years,ask Cathie Woods.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:TXG VS S&P 500 (SPY)

NASDAQ:TXG Summary

Fools bullish on NASDAQ:TXG are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about TXG.

Recs

1
Member Avatar johnny05 (24.86) Submitted: 2/17/2021 7:05:08 PM : Outperform Start Price: $183.44 NASDAQ:TXG Score: -26.76

Genomics is where you want to invest the next few years,ask Cathie Woods.

Recs

0
Member Avatar JedLloren (< 20) Submitted: 10/23/2020 12:28:52 PM : Outperform Start Price: $144.47 NASDAQ:TXG Score: -18.02

This company is responsible for creating gene sequencing technology that is used by scientific researchers. 10x Genomics is essentially helping research in one of the most crucial areas, of the coming decade, to take place.

Recs

0
Member Avatar marekz (67.56) Submitted: 10/8/2020 10:09:05 AM : Outperform Start Price: $149.17 NASDAQ:TXG Score: -21.85

10X is already a rapidly growing genetics research and test equipment (good combination) company. Now they have made a major play by acquiring two In Situ companies. This lets them measure large numbers of molecules directly in tissue at sub-cellular resolution. These approaches are complementary to the company's existing testing platforms. With In Situ, They hope this leads to a third technology platform. In short this expands a leadership area of genetics into a yet another area of genetics research that will catapult them into larger market shares of a rapidly growing market segment.

Leaderboard

Find the members with the highest scoring picks in TXG.

Score Leader

TMFSarahGen

TMFSarahGen (97.79) Score: +179.47

The Score Leader is the player with the highest score across all their picks in TXG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFSarahGen 97.79 10/10/2019 Outperform 5Y $49.50 +234.64% +55.17% +179.47 0 Comment
sharktrade 50.50 12/19/2019 Outperform 5Y $69.56 +138.11% +42.48% +95.63 0 Comment
CMFBLSH 90.56 1/2/2020 Outperform 5Y $76.91 +115.36% +40.91% +74.44 1 Comment
jck444 97.91 6/9/2020 Outperform 5Y $80.91 +104.71% +42.54% +62.17 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. CBK 51.34 6/8/2020 Outperform 5Y $82.06 +101.85% +42.48% +59.37 1 Comment
camcaid28 83.91 4/30/2020 Outperform 5Y $81.06 +104.33% +56.42% +47.91 0 Comment
smgod1 43.56 8/7/2020 Outperform 5Y $97.94 +69.11% +36.53% +32.58 0 Comment
TDogg 75.77 9/1/2020 Outperform 5Y $110.50 +49.89% +30.21% +19.68 0 Comment
cheev 100.00 9/1/2020 9/10/2021 Outperform 5Y $110.50 +49.89% +30.21% +19.68 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Juvenal 99.65 9/1/2020 Outperform 5Y $110.50 +49.89% +30.21% +19.68 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TXG.